Results Explained
/ Articles GLP-1s - What We Know Right Now, For Now (Part 3) Authors: Caitlin Munro, PharmD (Senior Manager, Clinical Programs), and Zach Brunko, PharmD (PGY-1 Managed Care Resident) In this final installment of GLP-1s, What We Know Now, For Now , we discuss to what extent increased competition in the market will create downward pressure in pricing and over what time period this is most likely to occur
The reduction, KFF found, is likely reflecting recent state budget challenges and the significant costs associated with coverage. Medicaid cuts within President Donald Trumps omnibus tax and spending bill could further exacerbate existing cost concerns, KFFs survey found (On the federal side, the Trump administration has sent mixed signals on GLP-1s, walking back a planned public coverage expansion in the spring but cutting a deal with drugmakers to expand Medicare access in the fall.) Still, the cost pressure of these drugs is acute in Pennsylvania, where lawmakers needed 135 extra days to cut a budget deal in part due to the states increasingly tough financial picture
For many people, the answer is yes, you can have some caffeine on Ozempic
While significant muscle growth takes longer, the improved nitrogen retention and protein synthesis create a fuller, more dense appearance to existing muscle tissue
While GHK-Cu peptide targets collagen genes directly, Thymalin works on immune cells that support tissue regeneration
